Discover Expert
Implementation Tips for Using Clinical Trials Data
Learn More!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Unresectable Malignant Neoplasm
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB00041
Aldesleukin
1
Terminated
1
DB16388
Axatilimab
1
Completed
1
DB01008
Busulfan
1
Terminated
1
DB04690
Camptothecin
1
Active Not Recruiting
1
DB00958
Carboplatin
1
Active Not Recruiting
1
DB11714
Durvalumab
1
Completed
1
DB00099
Filgrastim
1
Terminated
1
DB01073
Fludarabine
1
Terminated
1
DB11694
Ilorasertib
1
Completed
1
DB00762
Irinotecan
1
Active Not Recruiting
1
DB01229
Paclitaxel
1
Active Not Recruiting
1
DB06809
Plerixafor
1
Terminated
1
DB01390
Sodium bicarbonate
1
Terminated
1
DB07232
Veliparib
1
Active Not Recruiting
2
DB00062
Albumin human
1 / 2
Recruiting
1
DB06013
Aldoxorubicin
1 / 2
Withdrawn
1
DB11945
Avelumab
1 / 2
Withdrawn
1
DB17465
CD-16 NK-92 cells
1 / 2
Withdrawn
1
DB00002
Cetuximab
1 / 2
Withdrawn
1
DB00515
Cisplatin
1 / 2
Recruiting
1
DB00531
Cyclophosphamide
1 / 2
Withdrawn
1
DB17529
ETBX-051
1 / 2
Withdrawn
1
DB17530
ETBX-061
1 / 2
Withdrawn
1
DB17533
GI-6301
1 / 2
Withdrawn
1
DB16479
Inbakicept
1 / 2
Withdrawn
1
DB01229
Paclitaxel
1 / 2
Recruiting
1
DB11595
Atezolizumab
2
Completed
1
DB05239
Cobimetinib
2
Completed
1
DB11714
Durvalumab
2
Recruiting
1
DB00650
Leucovorin
2
Recruiting
1
DB06192
Nimotuzumab
2
Recruiting
1
DB00526
Oxaliplatin
2
Recruiting
1
DB09037
Pembrolizumab
2
Completed
1